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Molecular typing has become indispensable in the detection of nosocomial transmission of bacterial pathogens and the identifi-
cation of sources and routes of transmission in outbreak settings, but current methods are labor-intensive, are difficult to stan-
dardize, or have limited resolution. Whole-genomemultilocus sequence typing (wgMLST) has emerged as a whole-genome se-
quencing (WGS)-based gene-by-gene typing method that may overcome these limitations and has been applied successfully for
several species in outbreak settings. In this study, genus-, genetic-complex-, and species-specific wgMLST schemes were devel-
oped for Citrobacter spp., the Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytoca, and Klebsiella pneumoniae and
used to type a national collection of 1,798 extended-spectrum-beta-lactamase-producing Enterobacteriaceae (ESBL-E) isolates
obtained from patients in Dutch hospitals. Genus-, genetic-complex-, and species-specific thresholds for genetic distance that
accurately distinguish between epidemiologically related and unrelated isolates were defined for Citrobacter spp., the E. cloacae
complex, E. coli, and K. pneumoniae. wgMLST was shown to have higher discriminatory power and typeability than in silico
MLST. In conclusion, the wgMLST schemes developed in this study facilitate high-resolutionWGS-based typing of the most
prevalent ESBL-producing species in clinical practice andmay contribute to further elucidation of the complex epidemiology of
antimicrobial-resistant Enterobacteriaceae. wgMLST opens up possibilities for the creation of aWeb-accessible database for the
global surveillance of ESBL-producing bacterial clones.
The continuing global spread of extended-spectrum-beta-lacta-mase-producing Enterobacteriaceae (ESBL-E) constitutes a
major public health threat in both health care and community
settings (1–4). Extended-spectrum beta-lactamases (ESBL) confer
resistance to the majority of beta-lactam antibiotics, including
third-generation cephalosporins, which limits the options for an-
timicrobial therapy and results in increased morbidity and mor-
tality and health care costs (5, 6). Infection control guidelines
recommend prevention of the spread of ESBL-E in health care
settings (7, 8). Molecular typing has become an important tool in
infection control, as it enables the detection of nosocomial trans-
mission of bacterial pathogens and the identification of sources
and routes of transmission in outbreak settings. Different molec-
ular typing methods have been used, ranging from fingerprint-
based methods, like pulsed-field gel electrophoresis (PFGE) and
amplified fragment length polymorphism (AFLP), to sequence-
based methods, like multilocus sequence typing (MLST) (9–11).
Although widely adopted, PFGE is labor-intensive and difficult to
standardize and has limited interlaboratory reproducibility (12–
14). AFLP is less time-consuming than PFGE but may have lower
discriminatory power for typing of Enterobacteriaceae (13, 15).
MLST targets 7 or 8 housekeeping genes, depending on theEntero-
bacteriaceae species involved. It is a relatively fast, accurate, and
reproducible strain-typing method, which has enabled the cre-
ation of an unambiguous nomenclature for bacterial clones. How-
ever, sequence conservation in housekeeping genes limits its
discriminatory power and thus its use in outbreak investigations
(16–18). Whole-genome sequencing (WGS) has emerged as an
ultimate typing tool that fits any bacterial species, study type, and
laboratory (19–27). Knowledge of the sequence of the entire ge-
nome, rather than of only a few loci, has greatly increased the
precision of molecular epidemiologic data and allows its use in
infection control, where questions of similarity of isolates focus on
recently diverged isolates. Although promising, the analysis, inter-
pretation, and interlaboratory comparability of WGS-based typ-
ing results are still challenging. Whole-genome multilocus se-
quence typing (wgMLST) is a WGS-based typing method that
extends MLST to the genome level (20). Today, such gene-by-
gene comparison of WGS data has been applied successfully for
several species in outbreak settings, but data for Enterobacteriaceae
and nonoutbreak settings are still limited (22–27). The aim of this
study was to develop representative wgMLST schemes for the
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most prevalent ESBL-E species and to define thresholds for
wgMLST-based genetic distance that reliably distinguish between
epidemiologically related and unrelated ESBL-E isolates.
MATERIALS AND METHODS
ESBL-E isolates. A national collection of ESBL-E isolates was prospec-
tively gathered in the SoM study, a multicenter cluster-randomized study
comparing different isolation strategies for known ESBL-E carriers that
was performed in 14 Dutch hospitals between 2011 and 2014 (28). ESBL-E
isolates were obtained from routine clinical cultures and from perianal
screening cultures that were taken during 690 repeated ward-based prev-
alence surveys performed in the participating hospitals. Descriptive char-
acteristics, including species, date of culture, specimen type, patient, prev-
alence survey, ward, and hospital, were recorded for each isolate.
Microbiological methods. Detection of ESBL-E in clinical cultures
was performed according to national and international guidelines (29,
30). Screening cultures consisted of perianal swabs that were preenriched
in a selective tryptic soy broth and subsequently cultured on a selective
ESBL screening agar (EbSA) (Cepheid Benelux, Apeldoorn, the Nether-
lands) as described previously (31). For all oxidase-negative Gram-nega-
tive bacteria that grew on the EbSA plate, species identification was per-
formed with Vitek MS (bioMérieux, Marcy l’Etoile, France), using the
Vitek MS Knowledge Base v1.1 (until January 2013) or v2.0 (from January
2013). The production of ESBL was phenotypically confirmed by the
combination disk diffusion method with cefotaxime (30g), ceftazidime
(30 g), and cefepime (30 g), both alone and combined with clavulanic
acid (10 g; Rosco, Taastrup, Denmark). Test results were considered
positive if the inhibition zone around the disk was5 mm larger for the
combination with clavulanic acid (29, 30).
WGS. EbSA plates were inoculated with phenotypically confirmed
ESBL-E isolates and incubated for 18 to 24 h at 35 to 37°C. For each isolate,
several colonies (about 5 l) of the culture were suspended in 300 l
microbead solution, which was subjected to DNA extraction with the
Ultraclean Microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad,
CA, USA). The DNA concentration and purity were measured using a
NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific, Wal-
tham, MA, USA) and the Qubit double-stranded DNA (dsDNA) HS and
BR assay kits (Life Technologies, Carlsbad, CA, USA). One nanogram of
bacterial DNA was used for library preparation. The DNA library was
prepared using the Nextera XT library preparation kit with the Nextera
XT v2 index kit (Illumina, San Diego, CA, USA). The library fragment
length was aimed at fragments with a median size of 575 bases and was
assessed with the Genomic DNA ScreenTape assay with the 2200 Tape-
Station system (Agilent Technologies, Waldbronn, Germany). Subse-
quently, the library was sequenced on either a MiSeq sequencer, using the
MiSeq reagent kit v2 generating 250-bp paired-end reads, or on a HiSeq
2500 sequencer, using the HiSeq Rapid SBS kit v2 generating 100-bp
paired-end reads (Illumina, San Diego, CA, USA). Sequencing was aimed
at a coverage of at least 60-fold. MiSeq data were processed with MiSeq
control software v2.4.0.4 and MiSeq Reporter v2.4 and HiSeq data with
bcl2fastq2 conversion software v1.8.4 (Illumina, San Diego, CA, USA).
Quality trimming of reads was performed with CLC Genomics Work-
bench 7.0.4 (Qiagen, Hilden, Germany) using a minimum Phred (Q)
score of 28. A random and blinded sample of eight isolates was sequenced
in duplicate.
De novo assembly. De novo assembly was performed using CLC
Genomics Workbench 7.0.4 (Qiagen, Hilden, Germany) with optimal
word sizes based on the maximum N50 (the largest scaffold length, N,
such that 50% of the assembled genome size is contained in scaffolds with
a length of at least N) value. For each assembled genome, the coverage
(mean depth), the number of scaffolds, the N50, the maximum scaffold
length, and the percentage of the expected genome size were determined.
Assembled genomes were excluded from further analysis if they did not
fulfill the following quality criteria: (i) coverage, at least 20; (ii) number of
scaffolds, at most 1,000; (iii) N50, at least 15,000 bases; (iv) maximum
scaffold length, at least 50,000 bases; and (v) assembled genome size, be-
tween 90% and 115% of the expected genome size.
WGS-based species identification, detection of ESBL-encoding
genes, and MLST. Assembled genomes were uploaded to the online
bioinformatics tools KmerFinder v2.0, ResFinder v2.1, and MLST v1.7
(Center for Genomic Epidemiology, Technical University of Denmark,
Lingby, Denmark) (32–34). Species identification was based on the “win-
ner takes it all” scoring method of KmerFinder. ESBL-encoding genes
were reported when at least 60% of the length of the best matching gene in
the ResFinder database was covered with a sequence identity of at least
90%. A nonstringent threshold for the percent alignment (60%) of ESBL-
encoding genes was used to account for the fact that short-read sequence
data are not optimal for the assembly of plasmids, which may occasionally
result in incomplete assembly of ESBL-encoding genes. Conventional
MLST schemes in MLST v1.7 were based on the publicly available Pub-
MLST.org database (http://www.pubmlst.org) and were available for Cit-
robacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca,
and Klebsiella pneumoniae (see Table S1 in the supplemental material).
For E. coli, the Achtman MLST scheme was used (35). A sequence type
(ST) was assigned when all MLST loci in the assembled genome perfectly
matched all MLST alleles of a known ST in the MLST database, i.e., 100%
sequence identity and 100% alignment for all alleles (32). When all MLST
loci perfectly matched known MLST alleles but the combination of alleles
was unknown in the database, isolates were classified as “unknown ST,
perfect match.” These isolates were considered typeable with MLST based
on their allele profiles. Isolates with a sequence identity below 100% for
one or more of the MLST loci were classified as “unknown ST, minor
mismatch,” and isolates with an alignment below 100% for one or more of
the MLST loci were classified as “unknown ST, major mismatch.” Isolates
with minor or major mismatches were considered nontypeable with
MLST.
Definition of WGS-based typing schemes. The MLST target de-
finer function of Ridom SeqSphere (Ridom, Münster, Germany) was
used to define target gene sets for all species with at least 10 isolates avail-
able. Depending on the number of available complete reference genomes,
typing schemes were developed at the genus level (Citrobacter spp.), ge-
netic-complex level (E. cloacae complex), or species level (E. coli, K. oxy-
toca, and K. pneumoniae). For each scheme, one annotated and publicly
available complete genome (chromosome) was used as a reference ge-
nome (see Table S2 in the supplemental material). Open reading frames
were extracted from the reference genomes and filtered by applying a
minimum-length filter that discarded all genes with a length below 50
bases; a start codon filter that discarded all genes that contained no start
codon at the beginning of the gene; a stop codon filter that discarded all
genes that contained no stop codon, more than one stop codon, or a
premature stop codon; an excluded sequences filter that discarded plas-
mid sequences; and a homologous gene filter that discarded all genes with
fragments that occurred in multiple copies within the genome (with a
sequence identity of at least 90% and more than 100-base overlap). Sub-
sequently, the remaining set of reference genome genes was compared to
a varying number of publicly available query genomes using the Basic
Local Alignment Search Tool (BLAST) (36). The type and number of
query genomes that were used differed by species and were dependent
on the availability of annotated genomes (see Table S2 in the supple-
mental material). A gene overlap filter was used to identify reference
genome genes that overlapped by more than 4 bases and to filter out
the shorter gene. In addition, a stop codon percentage filter was ap-
plied to filter out genes that contained no stop codon, more than one
stop codon, or a premature stop codon in more than 80% of the query
genomes.
Reference genome genes that passed the gene overlap filter and the
stop codon percentage filter were designated whole-genome targets. Of
those, genes that were present in all query genomes with a sequence iden-
tity of at least 90% and an alignment of 100% were classified as core
genome targets; the remaining genes were classified as accessory genome
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targets. wgMLST schemes included all whole-genome targets; core ge-
nome MLST (cgMLST) schemes included only the core genome targets.
An overview of the typing schemes, including the number of core, acces-
sory, and whole-genome targets per typing scheme, is provided in Table
S3 in the supplemental material.
Genetic distance. For each assembled genome, all whole-genome tar-
get genes that were present with a sequence identity of at least 90% and an
alignment of 100% were extracted using Ridom SeqSphere software v
3.0 (Ridom, Münster, Germany). Genes that could not be identified in the
assembled genome were classified as “missing targets.” Genes with an
alignment below 100% or a sequence identity below 90% were classified as
“failed targets.” The remaining genes were classified as “good targets.” To
evaluate the applicability and representativeness of the core genome target
set, the percentage of good core genome targets was assessed for all assem-
bled genomes. Assembled genomes for which the percentages of good
core genome targets were below 90% were excluded from further analyses.
All-to-all distance matrices, describing pairwise genetic distances, were
constructed separately for core, accessory, and whole-genome target gene
sets. The pairwise genetic distance was defined as the proportion of allele
differences and was calculated by dividing the number of allele differences
by the total number of good targets shared by both sequences, i.e., pair-
wise ignoring missing values.
Classification of pairwise comparisons. Pairwise comparisons of as-
sembled genomes were classified according to the known epidemiological
link between the isolates: (i) same patient; (ii) same survey but different
patients; (iii) same ward but different surveys and patients; (iv) same
hospital but different wards, surveys, and patients; and (v) no known
epidemiological link, i.e., different hospitals, wards, surveys, and patients.
Definition of epidemiologically related and unrelated isolates. In
the absence of a gold standard molecular typing method with perfect
discriminatory power, epidemiological-link data were used to define re-
lated and unrelated isolates, where maximal contrast between related and
unrelated isolates was sought. Epidemiologically related isolates were de-
fined as being obtained from the same patient, belonging to the same ST,
and cultured within a time window of 30 days. The last two restrictions
were added to exclude potential bias from simultaneous carriage of mul-
tiple ESBL-E isolates from different clonal lineages and within-patient
microevolution of isolates over time. Epidemiologically unrelated isolates
were defined as being obtained from patients without any known epide-
miological link.
Statistical analysis. The Kruskal-Wallis H test and sign test were used
to test for differences in median genetic distance between species and
between core and accessory genomes, respectively. All analyses were per-
formed with IBM SPSS Statistics v22 (IBM Corp., Armonk, New York,
USA).
Ethical considerations. This study was reviewed by the Medical Re-
search and Ethics Committee (MREC) of the Elisabeth/TweeSteden Hos-
pital (Tilburg, the Netherlands) in December 2010. The study was judged
to be beyond the scope of the Medical Research Involving Human Sub-
jects Act (in Dutch, Wet Medisch-wetenschappelijk Onderzoek met
Mensen [WMO]), and a waiver of written informed consent was obtained
(METC/jv/2010.034). Patients who participated in the study provided
verbal consent for use of demographic, clinical, and culture data.
Accession number(s). All generated raw reads were submitted to the
European Nucleotide Archive (ENA) of the European Bioinformatics In-
stitute (EBI) under the study accession number PRJEB15226.
RESULTS
A total of 2,005 phenotypic ESBL-E isolates were collected and
available for WGS (Fig. 1). No ESBL-encoding gene could be de-
tected in the assembled genomes of 160 (8.0%) isolates. For 26
(1.3%) isolates, the assembly was of insufficient quality. A sum-
mary of assembly characteristics for 1,819 genotypic ESBL-E iso-
lates with good quality WGS data is provided in Table S4 in the
supplemental material. WGS-based species identification was in
accordance with that of Vitek-MS for 1,808 isolates. For 11 isolates
that were identified as Citrobacter spp. by Vitek-MS, KmerFinder
did not provide a high-confidence result for any species, probably
due to the limited number of Citrobacter sp. reference genomes in
the database. No wgMLST scheme was developed for Enterobacter
aerogenes (n  5), Leclercia adecarboxylata (n  1), Morganella
morganii (n 9), Proteusmirabilis (n 2), or Raoultella spp. (n
3). One E. coli isolate for which only 71.4% of core genome targets
could be detected in the assembled genome was excluded from
wgMLST analyses. For the remaining 1,798 ESBL-E isolates, the
percentage of core genome targets present in the assembled ge-
nomes was at least 90.0% (see Table S5 in the supplemental
material), which is indicative of the representativeness of the
wgMLST schemes for the ESBL-E population studied. As ex-
pected, the percentage of accessory genome targets present in the
FIG 1 Availability of ESBL-E isolates for WGS and wgMLST.
wgMLST of ESBL-Producing Enterobacteriaceae
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assembled genomes varied considerably within and between spe-
cies.
The sequence identity of the ESBL-encoding genes that were
identified was 100% for 1,751 (97.6%) ESBL-E isolates. For the
remaining 47 (2.4%) isolates, the percent sequence identity with
known ESBL-encoding genes ranged from 99.1% to 99.9%. The
percent alignment of the ESBL-encoding genes was 100% for
1,789 isolates (99.5%) and ranged from 66.6% to 97.9% for the
other 9 (0.5%) isolates.
The all-to-all genetic distance matrices comprised 950,275
unique pairwise comparisons. Figure 2 shows the species-specific
distributions of genetic distance for core and accessory genome
targets. Pairwise genetic distances ranged from 0.000 to (approx-
imately) 1.000 for both core and accessory genomes and for all
species. However, the distribution of genetic distances differed
significantly between species (P 0.0005) and between core and
accessory genomes (P  0.0005). For the core genome, median
genetic distances ranged from 0.609 for Citrobacter spp. to 0.965
for K. oxytoca and, for the accessory genome, from 0.748 for Cit-
robacter spp. to 0.995 for K. oxytoca. For all species, the median
genetic distance was higher for the accessory genome than for the
core genome. Summary statistics of the distribution of numbers of
alleles compared; numbers of different alleles; and genetic dis-
tances for core genome, accessory genome, and whole genome are
presented by species in Table S6 in the supplemental material. To
assess the added value of the accessory genome in terms of genetic
distance, the difference between whole-genome and core genome
genetic distances was calculated for each pairwise comparison
(Fig. 3). For the majority of pairwise comparisons (82.0%
[779,316/950,275]), the whole-genome genetic distance was larger
than the core genome distance, although the absolute difference dif-
fered between species. For the remaining comparisons, the inclusion
of accessory genome targets reduced the genetic distance. Five E. coli
and threeK. pneumoniae isolates were sequenced in duplicate. The
results were found to be reproducible, with genetic distances rang-
ing from 0.000 to 0.001 for both core and whole-genome targets.
Table 1 provides the distributions of genetic distances for iso-
lates with the same (conventional) ST and isolates with different
FIG 2 Distribution of genetic distances for 950,275 pairwise comparisons of extended-spectrum beta-lactamase-producing Enterobacteriaceae, shown separately
for core genome and accessory genome. The boxes represent the interquartile (IQ) range. The whiskers extend to the highest and lowest values that are not greater
than 1.5 times the IQ range. The lines across the boxes indicate the medians. The circles represent outliers, i.e., comparisons with values more than 1.5 times the
IQ range. n defines the number of pairwise comparisons for each species. Kruskal-Wallis chi-square test results for difference between species were as follows:
chi-squarecore genome 22,685, P 0.0005; chi-squareaccessory genome 15,980, P 0.0005. Sign test for the difference between core and accessory genomes,P 0.0005.
FIG 3 Distribution of the differences in genetic distance between whole ge-
nome and core genome for 950,275 pairwise comparisons of extended-spec-
trum beta-lactamase-producing Enterobacteriaceae. The boxes represent the
IQ range. The whiskers extend to the highest and lowest values that are not
greater than 1.5 times the IQ range. The lines across the boxes indicate the
medians. The circles represent outliers, i.e., pairwise comparisons with values
more than 1.5 times the IQ range. n defines the number of pairwise compari-
sons for each species. Kruskal-Wallis chi-square test results for difference be-
tween species were as follows: chi-square 69,760, P 0.0005.
Kluytmans-van den Bergh et al.
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STs. As expected, wgMLST and cgMLST enabled further differen-
tiation of isolates that belong to the same ST. The broadest with-
in-ST ranges in genetic distance were observed for E. coli and K.
pneumoniae, with ranges from 0.000 up to 0.520 and from 0.000
up to 0.566 (wgMLST), respectively. Although median genetic
distances clearly differed for within-ST and between-ST compar-
isons, the ranges of genetic distances overlapped for E. cloacae, E.
coli, and K. pneumoniae, indicating that some isolates with differ-
ent STs can be genetically more closely related than isolates with
the same ST. For 47,748 (5.0%) pairwise comparisons, no ST
could be assigned to either of the isolates because of minor or
major mismatches for at least one of the seven alleles involved.
The distributions of genetic distances for epidemiologically re-
lated and unrelated isolates were clearly different. Figure 4 shows
the distributions of wgMLST-based genetic distances for epidemi-
ologically related and unrelated ESBL-producing E. coli. Compa-
rable distributions were observed for epidemiologically related
and unrelated isolates of the other ESBL-E species (see Fig. S1 in
the supplemental material) and for cgMLST-based genetic dis-
tances (data not shown). Based on these distributions for epide-
miologically related and unrelated isolates, thresholds for genetic
distance were set at the minimal value that classified 100% of
epidemiologically related isolate pairs as clonally related (Table 2).
The absence of a pair of epidemiologically related K. oxytoca iso-
lates in the ESBL-E strain collection precluded the definition of
thresholds for K. oxytoca. Thresholds differed between species,
with two to three times higher values for E. coli than for the other
three species. Thresholds for cgMLST- and wgMLST-based ge-
netic distances were similar for Citrobacter spp. and the E. cloacae
complex but differed slightly for E. coli (a lower threshold for
wgMLST) and K. pneumoniae (a lower threshold for cgMLST).
For all genetic distance thresholds, the corresponding percentage
of presumed epidemiologically unrelated isolate pairs that were
classified as clonally related was low (0.1% to 0.5%), which indi-
cates high discriminatory power, i.e., the ability to assign different
types to different isolates (37).
Thresholds for genetic distance were subsequently used to type
all 1,798 ESBL-E isolates, and the results were compared with
those of in silico MLST (Table 3). Epidemiological concordance
was observed for all three typing methods, i.e., the percentage of
isolates identified as clonally related was highest for within-patient
comparisons and decreased with waning degrees of epidemiolog-
ical linkage. The typeability, i.e., the percentage of isolates to
which a genotype could be assigned, was significantly higher for
cgMLST and wgMLST (99.98%) than for in silico MLST (95.0%;
P 0.0005) (37). In addition, cgMLST and wgMLST had higher
discriminatory power than in silico MLST, i.e., classification of
presumed epidemiologically unrelated isolates as clonally related
was significantly less frequent for cgMLST (0.5%) and wgMLST
(0.3%) than for in silico MLST (7.1%, P  0.0005). Extending
cgMLST to wgMLST resulted in a 0.2% increase in the overall
percentage of correct classification of presumed epidemiologically
TABLE 1 Genetic distances for pairwise comparisons of ESBL-E isolates within and between conventional MLST STsa
MLST and species





Median Range Median Range
cgMLST
Citrobacter spp. 14 0.000 [0.000–0.036] 31 0.897 [0.537–0.917]
E. cloacae complex 430 0.006 [0.000–0.104] 5,135 0.881 [0.088–0.987]
E. coli 67,108 0.022 [0.000–0.507] 796,847 0.966 [0.019–0.985]
K. oxytoca 1 0.066 [0.066–0.066] 65 0.992 [0.789–0.996]
K. pneumoniae 929 0.020 [0.000–0.542] 31,967 0.844 [0.090–0.998]
wgMLST
Citrobacter spp. 14 0.000 [0.000–0.027] 31 0.913 [0.558–0.933]
E. cloacae complex 430 0.007 [0.000–0.129] 5,135 0.902 [0.102–0.988]
E. coli 67,108 0.027 [0.000–0.520] 796,847 0.968 [0.021–0.986]
K. oxytoca 1 0.070 [0.070–0.070] 65 0.994 [0.795–0.996]
K. pneumoniae 929 0.022 [0.000–0.566] 31,967 0.870 [0.104–0.997]
a Excluding 47,748 (5.0%) pairwise comparisons for which no ST could be assigned to either of the isolates.
FIG 4 Distributions of wgMLST-based genetic distances for pairwise compar-
isons of epidemiologically related and unrelated extended-spectrum beta-lac-
tamase-producing Escherichia coli isolates. Epidemiologically related isolates
were defined as being obtained from the same patient, belonging to the same
ST, and cultured within a time window of 30 days. Epidemiologically unrelated
isolates were defined as being obtained from patients without a known epide-
miological link.
wgMLST of ESBL-Producing Enterobacteriaceae
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unrelated isolates as clonally unrelated (P 0.0005). In addition,
reclassification analysis of individual comparisons showed that
extension to wgMLST improved classification for 1,551 of 840,338
(0.2%) epidemiologically unrelated isolate pairs, i.e., presumed
epidemiologically unrelated isolate pairs were reclassified from
clonally related (cgMLST) to clonally unrelated (wgMLST) (Table
4). On the other hand, 44 of 840,338 (0.005%) presumed epide-
miologically unrelated isolate pairs were classified as clonally re-
lated by wgMLST, while they were classified as clonally unrelated
by cgMLST.
DISCUSSION
In this study, representative genus-, genetic-complex-, and spe-
cies-specific wgMLST schemes were developed for the five most
prevalent Enterobacteriaceae species in clinical practice and used
to type a large national collection of ESBL-E isolates obtained
from patients in Dutch hospitals. Genus-, genetic-complex-, and
species-specific thresholds for genetic distance that accurately dis-
tinguished between epidemiologically related and unrelated iso-
lates were defined for Citrobacter spp., the E. cloacae complex, E.
coli, and K. pneumoniae. wgMLST was shown to have higher dis-
criminatory power and typeability than in silico MLST.
After the introduction of WGS as a typing tool with high po-
tential, gene-by-gene comparison of WGS data has been applied
successfully for several species in outbreak settings (22–27). To
our knowledge, this large multicenter study is the first to apply
wgMLST for typing of Enterobacteriaceae in nonoutbreak settings
and to include a comprehensive evaluation of its performance in a
large collection of isolates without a clear epidemiological link.
The availability of detailed epidemiological data enabled the def-
inition of thresholds for wgMLST-based genetic distance that can
be used to distinguish between epidemiologically related and un-
related isolates in hospital settings and provided estimates of the
probability of classifying presumed epidemiologically unrelated
isolates as clonally related in settings with low levels of transmis-
sion.
Available studies on WGS-based typing have shown that reli-
able phylogenies with good resolution can be inferred from the
core genome (16). It has been suggested, though, that resolution at
the isolate level may be further improved by the additional target-
ing of more variable genes from the accessory genome (16). In the
present study, wgMLST resulted in a larger genetic distance be-
tween isolates than cgMLST for the majority of isolate compari-
sons and in less frequent classification of presumed epidemiolog-
ically unrelated isolates as clonally related and thus had slightly
higher discriminatory power. Based on these findings, the use of
TABLE 2 Thresholds for genetic distance with corresponding















Citrobacter spp. 0.0030 693 1 0.1
E. cloacae complex 0.0035 6,256 31 0.5
E. coli 0.0105 802,437 3,999 0.5
K. pneumoniae 0.0035 30,808 75 0.2
wgMLST
Citrobacter spp. 0.0030 693 1 0.1
E. cloacae complex 0.0035 6,256 17 0.3
E. coli 0.0095 802,437 2,485 0.3
K. pneumoniae 0.0045 30,808 96 0.3
a The absence of a pair of epidemiologically related K. oxytoca isolates precluded the
definition of thresholds for K. oxytoca.
b Thresholds were set at the minimal value for genetic distance that classified 100% of
epidemiologically related ESBL-E isolates as clonally related.
c Epidemiologically related isolates were those obtained from the same patient,
belonging to the same ST, and cultured within a time window of 30 days.
Epidemiologically unrelated isolates were those obtained from patients without a
known epidemiological link. Clonally related isolates were those at a genetic distance
below or equal to the threshold value.
TABLE 3 Typing results for 950,275 pairwise comparisons of ESBL-E










n % n % n %
Same patient (n 726)
MLST 550 75.8 136 18.7 40 5.5
cgMLST 564 77.7 161 22.2 1 0.1
wgMLST 565 77.8 160 22.0 1 0.1
Same survey (n 1,180)
MLST 168 14.2 930 78.8 82 6.9
cgMLST 129 10.9 1,051 89.1 0 0.0
wgMLST 131 11.1 1,049 88.9 0 0.0
Same ward (n 14,291)
MLST 1,165 8.2 12,465 87.2 661 4.6
cgMLST 329 2.3 13,960 97.7 2 0.0
wgMLST 301 2.1 13,988 97.9 2 0.0
Same hospital (n 93,740)
MLST 6,908 7.4 82,414 87.9 4,418 4.7
cgMLST 921 1.0 92,813 99.0 6 0.0
wgMLST 778 0.8 92,956 99.2 6 0.0
Other hospital (n 840,338)
MLST 59,691 7.1 738,100 87.8 42,547 5.1
cgMLST 4,106 0.5 836,088 99.5 144 0.0
wgMLST 2,599 0.3 837,595 99.7 144 0.0
a MLST, unknown ST, minor or major mismatch (n 47,748); cgMLST/wgMLST, no
cutoff available for K. oxytoca (n 153).
TABLE 4 Reclassification of clonal (un)relatedness of epidemiologically
unrelated ESBL-E isolates after extension of cgMLST to wgMLST
Pairwise comparison
by cgMLST





Clonally related 2,555 1,551 0
Clonally unrelated 44 836,044 0
Nontypeable 0 0 144a
a All nontypeable isolates were K. oxytoca isolates.
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wgMLST is preferred over cgMLST for the Enterobacteriaceae spe-
cies studied here. However, extension with the accessory genome
was shown to result in a decrease in genetic distance for a minority
of isolates and in rare cases even in classification of presumed
epidemiologically unrelated isolates as clonally related.
Thresholds for genetic distance that distinguished epidemio-
logically related from unrelated isolates differed between species
and were highest for E. coli. These high thresholds for E. coli may
reflect higher mutation and recombination rates or may be related
to within-patient microevolution of coexisting isolates with com-
mon ancestry. Estimates of the mutation and recombination rates
of Enterobacteriaceae are limited and range from 0 to 10 mutations
per genome per year (38, 39). These rates reflect fixed substitution
rates; short-term mutation (polymorphism) rates may be higher
and are known to increase under antibiotic pressure or other en-
vironmental stress (40).
Due to the lack of K. oxytoca isolate pairs that fulfilled the
definition of epidemiologically related isolates, thresholds for
genetic distance for the species are still to be defined. The dis-
tribution of genetic distances for epidemiologically unrelated
K. oxytoca isolates was comparable to that of the other Enterobac-
teriaceae species and might be used to evaluate proposed thresh-
olds in future studies.
wgMLST was shown to have high discriminatory power.
With genetic distance thresholds set at the minimal value that
classified 100% of epidemiologically related isolates as clonally
related, only 0.3% of presumed epidemiologically unrelated
isolates were classified as clonally related. Thus, wgMLST may
enable high-resolution detection of nosocomial transmission
of antimicrobial-resistant Enterobacteriaceae. Classification of
presumed epidemiologically unrelated isolates as clonally re-
lated may be due to a residual lack of resolution of wgMLST but
may also reflect the presence of an unidentified epidemiologi-
cal link in the hospital or community setting. Other possible
explanations may be related to clone-specific characteristics,
such as a low mutation rate, converging evolution, or recent
introduction into the human population.
Interestingly, about 20% of within-patient comparisons were
found to pertain to clonally unrelated isolates, indicating that pa-
tients are cocolonized with multiple ESBL-producing isolates.
This finding may reflect multiple acquisitions of ESBL-E but may
also be the result of within-patient horizontal transfer of ESBL-
encoding mobile genetic elements.
An important strength of wgMLST is the use of alleles and not
nucleotide polymorphisms as units of comparison. Irrespective of the
number of nucleotide polymorphisms involved, each allelic change is
numbered as a single event, i.e., an allelic change is related to at least
one point mutation, but can also contain several nucleotide changes.
Thus, allele-based methods largely reduce the conflicting signals of
recombination in determining genetic relatedness of bacteria (41–
45). Another major advantage of this gene-by-gene allelic profiling
method is the immediate and automated assignment of novel allele
variants, which enables a standardized and universal nomenclature
and is a prerequisite for successful interlaboratory exchange of data
(46). Most studies on wgMLST have used the absolute number of
allele differences to compare isolates, which is highly dependent on
the number of targets that are compared (22, 23, 26, 27). In the pres-
ent study, differences in the numbers of targets compared were taken
into account by defining genetic distance as the proportion of allele
differences. This enabled the unbiased comparison of genetic dis-
tances for different pairwise comparisons and the definition of
thresholds for genetic distance.
A limitation of allele-based typing is that the analysis is reduced to
coding regions only, as second-generation sequencing platforms cur-
rently in use produce only relatively short reads that do not facilitate
high-quality assembly of highly repetitive intergenic regions. This
might change when third-generation sequencing instruments that
produce much longer reads from a single molecule become widely
available. Nevertheless, the current wgMLST approach will be sus-
tainable, as it will maintain backward compatibility with the expan-
sion of typing schemes, as we see today with the in silico extraction of
conventional MLST sequence types from WGS data.
In conclusion, the wgMLST schemes developed in this study
facilitate high-resolution WGS-based typing of the most prevalent
ESBL-producing species in clinical practice and may contribute to
further elucidation of the complex epidemiology of antimicrobi-
al-resistant Enterobacteriaceae. wgMLST opens up possibilities for
the creation of a Web-accessible database for the global surveil-
lance of ESBL-producing bacterial clones.
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